Researchers from the Korea Advanced Institute of Science and Technology (KAIST) have developed a wearable green organic light-emitting diode (OLED) with a 470-nanometer (nm) wavelength that can cure jaundice in infants.
The OLED provides sufficient power for jaundice treatment even at low voltage, durability for over 100 hours of operation, a low operating temperature of less than 35 Celsius degrees, and flexibility that can endure over 1,000 bends at a 2 mm radius of curvature.
The bilirubin level of the infants’ serum reaches 12 milligrams per decilitre (mg/dL) within three hours of being exposed to the OLED, indicating the completed treatment of jaundice.
Unlike existing light-emitting diode (LED)-based jaundice treatment devices currently used at hospitals, the OLED showed uniform and effective treatment functions.


Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation
Momenta Quietly Moves Toward Hong Kong IPO Amid Rising China-U.S. Tensions
BOJ Faces Pressure for Clarity, but Neutral Rate Estimates Likely to Stay Vague
Japan’s Nikkei Drops as Markets Await Key U.S. Inflation Data
ExxonMobil to Shut Older Singapore Steam Cracker Amid Global Petrochemical Downturn
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Amazon Italy Pays €180M in Compensation as Delivery Staff Probe Ends
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy
IMF Deputy Dan Katz Visits China as Key Economic Review Nears
U.S. Futures Steady as Rate-Cut Bets Rise on Soft Labor Data
Asian Currencies Steady as Markets Await Fed Rate Decision; Indian Rupee Hits New Record Low
Citi Sets Bullish 2026 Target for STOXX 600 as Fiscal Support and Monetary Easing Boost Outlook
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 



